Meet the team

Jonathann Kuo, MD

Founder & Medical Director

Jonathann Kuo, MD is a leader in the interventional mental health space, spearheading multiple clinical trials to study and refine innovative treatments that are transforming mental health care. Dr. Kuo works hand in hand with top psychiatrists and MDs like Dr. Eugene Lipov for Dual Sympathetic Blocks, Dr, Owen Muir for Transcranial Magnetic Stimulation, and Dr. Albert Brooks and Dr. Casey Paleos for Psychedelic Therapies. Together, this team of industry leaders is developing the new frontier of mental health care.

Dr. Kuo has performed hundreds of Dual Sympathetic Blocks and is considered a thought leader in the fight against PTSD and other mood disorders.
Jonathann Kuo, MD is a double Board-Certified Pain Management Specialist and Anesthesiologist. He is the founder of Hudson Health, an innovative healthcare system with four integrated practices: Hudson Medical for pain management, Hudson Wellness for preventative wellness, Hudson Mind for interventional mental health, and Hudson Life for functional and longevity medicine.

Under Dr. Kuo’s direction, Hudson Health takes a multidisciplinary approach to care, combining Eastern traditions with the latest Western protocols and advancements in bioscience. This unified system treats each patient’s health in totality while prioritizing disease reversal and healthspan optimization.
Dr. Kuo graduated from the prestigious 7 year accelerated BA/MD program at Boston University. He then completed his training at one of New York’s top institutions, New York Presbyterian Hospital. He received additional fellowship training in Pain Management at Memorial Sloan Kettering Hospital and the Hospital for Special Surgery. He is certified in peptide therapies and has completed advanced coursework through SSRP and the American Academy of Anti-Aging Medicine
Dr. Kuo and his Hudson Health team are “Experts in Pain,” having treated over 50K patients in 14 years. The Hudson team maintains its high standard of care by employing an in-house algorithm called The Hudson Method to treat pain in the most efficient and efficacious way for each and every patient.

Over the course of his 13-year career, Dr. Kuo has become a renowned leader in interventional orthopedics, having performed over 30,000 x-ray and ultrasound-guided spinal and joint procedures.His constant drive for innovation and excellence, combined with intellectual and academic curiosity, has also brought him to the forefront of the rapidly advancing anti-aging, regenerative fields and interventional mental health fields.
Dr. Kuo actively contributes to clinical research that evaluates the newest biologics and their applications in degenerative spinal and joint and systemic inflammatory conditions. He has traveled extensively to leading laboratories to collaborate with global thought leaders in the regenerative field. Hudson Health’s robust Regenerative Medicine practice has performed over 2000 cases to date with proprietary methods of extracting the highest concentrations of biologics using a flexible lab platform. Hudson Medical is also the first practice in the US to publish safety data on the use of exosomes in spinal applications, and Dr. Kuo is committed to continually spearheading research in this field.
Dr. Kuo has created a comprehensive interventional mental health under Hudson Mind. The three pillars of this program include Dual Sympathetic blocks for PTSD and anxiety, Ketamine Infusions for chronic pain and depression, and Transcranial Magnetic Stimulation for depression and OCD. Having administered over 1,000 Dual Sympathetic Blocks, Dr. Kuo is already a sought-after interventional mental health thought leader. Under his leadership, Hudson Mind facilitates research for upcoming studies on emerging interventions, including Psilocybin and MDMA.

Clinicial work and published papers

SGB for Anxiety

Research Paper

“SGB attenuates sympathetic outflow from the SG and provides anxiety symptom relief by restoring dysregulated SNS signaling. When used in conjunction with psychotherapy, SGBs have a 70%-80% success rate in treating anxiety and PTSD symptoms (16, 19-20).”
Stellate Ganglion Block for Long COVID

Research Paper

“The significant improvement of long COVID symptoms following bilateral SGBs described in these case studies indicate an important role of dysautonomia and cerebral blood flow in the pathophysiology of long COVID (16).”

Clinical Trial

This study will enroll patients meeting Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria for post-traumatic stress disorder (PTSD). Following an initial screening visit, clinical assessment, and enrollment, subjects will be randomized into treatment and placebo arms.

Meet the Team

Marcel Green, MD


Alessandra Fabris-Tantawi Cropped Portrait
Alessandra Fabris-Tantawi LMSW, M.Ed

Psychotherapist / Integrative Somatic Trauma Specialist

Brandon Lau, PA

Physicians Assistant

Tasha Ednie

Operations Manager

Leigh Harlow

TMS Technician & Operations Associate